Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.05
-0.15 (-2.88%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $140.67 million as of September 2, 2026. Its market cap has increased by 90.09% in one year.
Market Cap
140.67M
Enterprise Value
79.92M
1-Year Change
90.09%
Ranking
Category
Stock Price
$5.05
ChartMarket Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $140.67M, an increase of 111.57%. That is a compound annual growth rate of 15.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 140.67M | 13.44% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 154.30M |
| Tenaya Therapeutics | 153.10M |
| Indaptus Therapeutics | 149.90M |
| NRx Pharmaceuticals | 149.69M |
| Kazia Therapeutics | 148.55M |
| Connect Biopharma Holdings | 145.47M |
| OnKure Therapeutics | 144.98M |
| Equillium | 140.13M |